Department of General Practice and Health Services Research, University Hospital Heidelberg, Germany.
BMJ Qual Saf. 2011 Jun;20(6):522-6. doi: 10.1136/bmjqs.2010.047357. Epub 2011 Jan 24.
BACKGROUND The German guideline recommends trimethoprim (TMP) for the treatment of uncomplicated lower-urinary-tract infections (uLUTI) in primary care. In the authors' research network, the participating general practitioners (GPs) were asked why they prescribe mostly quinolones instead. The GPs stated the perception of a high rate of therapy failure of TMP and strongly rejected the guideline. OBJECTIVE To examine prescribing behaviour for uLUTI and whether a practice test of TMP might effect a change in prescribing habits. METHODS The study was conducted using observational and qualitative elements. A first focus-group (n=6) assessed reasons for current prescribing behaviour. In a 3-month practice test, patients with uLUTI were prescribed TMP (150 mg twice for 3 days). In a second focus group, the GPs (n=12) were presented with the results of the practice test. RESULTS The first focus group revealed that prescribing was mainly driven by former hospital training and what was perceived as common therapy. GPs felt no need to change a successful regimen. In the practice test, TMP had a success rate of 94% (84 episodes of uLUTI). The second focus group revealed that the practice test had strongly changed opinions in favour of TMP. Self-reflection and ownership of data acquisition were seen as major contributions for change in prescribing. After the test period, TMP remained the antibiotic most often prescribed. CONCLUSION Internal evidence and peer-group opinion are strong determinants for clinical decisions. A self-conducted practice test, together with self-reflection in a peer group, strongly supports the process of change.
德国指南建议在初级保健中使用甲氧苄啶(TMP)治疗单纯性下尿路感染(uLUTI)。在作者的研究网络中,要求参与的全科医生(GP)说明他们为何大多选择开喹诺酮类药物而不是 TMP。GP 表示 TMP 的治疗失败率很高,强烈反对该指南。目的:检查 uLUTI 的处方行为,以及 TMP 的实践测试是否可能改变处方习惯。方法:本研究采用观察性和定性研究方法。第一个焦点小组(n=6)评估了当前处方行为的原因。在 3 个月的实践测试中,患有 uLUTI 的患者被开具 TMP(150 mg 两次,连用 3 天)。在第二个焦点小组中,向 12 名 GP 介绍了实践测试的结果。结果:第一个焦点小组揭示了处方主要受以前的医院培训和被认为是常见治疗方法的驱动。GP 认为没有必要改变成功的治疗方案。在实践测试中,TMP 的成功率为 94%(84 例 uLUTI)。第二个焦点小组显示,实践测试强烈改变了对 TMP 的看法。自我反思和对数据采集的所有权被视为改变处方的主要贡献。测试期结束后,TMP 仍然是最常开的抗生素。结论:内部证据和同行意见是临床决策的重要决定因素。自我进行的实践测试以及在同行小组中的自我反思强烈支持变革过程。